Skip to main content
SkinCited

Polypodium leucotomos per UV Protection (Internal Photoprotection)

B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.

A systematic review found oral PLE significantly increased MED by 1.5-2.8x. The American Academy of Dermatology has acknowledged PLE as a potential adjunct to topical sunscreen.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dpolypodium\u002Dleucotomos\u0026condition\u003Duv\u002Dprotection'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

A systematic review found oral PLE significantly increased MED by 1.5-2.8x. The American Academy of Dermatology has acknowledged PLE as a potential adjunct to topical sunscreen.

Key Study Findings

Systematic Review
Oral Supplements and Photoprotection: A Systematic Review.
Dose: None vs: Placebo/no supplement Outcome: Photoprotective effects (MED, erythema) Effetto: None None

Popolazione: Healthy adults (47 studies in systematic review)

Key Statistics

5

Studi

250

Partecipanti

Positive

B

Grado

Referenced Papers

Journal of medicinal … 2025 3 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
240-480 mg/day
photoprotection:
480 mg/day (240 mg twice daily, 30-60 min before sun exposure)

Limite massimo: Generally well-tolerated up to 960 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --

Momento migliore per l'assunzione: 30-60 minutes before sun exposure; can also be taken daily for baseline protection

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated
  • Mild gastrointestinal discomfort (rare)
  • Pruritus (rare)

Interazioni note

  • Immunosuppressants (may modulate immune function)
  • Photosensitizing medications (may modulate UV response)

Livello di assunzione massimo tollerabile: Generally well-tolerated up to 960 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Polypodium leucotomos help with UV Protection (Internal Photoprotection)?
Based on 5 studies with 250 participants, there is moderate evidence from clinical studies that Polypodium leucotomos may support UV Protection (Internal Photoprotection) management. Our evidence grade is B (Good Evidence).
How much Polypodium leucotomos should I take for UV Protection (Internal Photoprotection)?
Studies have used various dosages. A commonly studied range is 240-480 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Polypodium leucotomos?
Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort (rare), Pruritus (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Polypodium leucotomos and UV Protection (Internal Photoprotection)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 250 total participants. The overall direction of effect is positive.

Polypodium leucotomos per altre condizioni

References

  1. [1] Nicole Natarelli et al.. J Med Food. 2025. Oral Supplements and Photoprotection: A Systematic Review. doi:10.1089/jmf.2024.0023 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.